Halopid 5 mg is a potent butyrophenone derivative with antipsychotic properties, used in the management of a wide range of neuropsychiatric and behavioral disorders. It is effective in controlling hyperactivity, agitation, mania, psychosis, and anxiety-related functional disorders. Halopid 5 mg also exhibits antiemetic properties and can potentiate the effects of CNS depressants. Its pharmacological actions primarily involve dopamine receptor antagonism, resulting in reduced aggressiveness, calmness, and alleviation of hallucinations and delusions.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Halopid 5 mg is indicated for:

Low Doses:

• Nervousness, anxiety states, and associated psychic disorders such as irritability, aggressiveness, and insomnia

• Functional disorders caused by anxiety: trembling, thoracic oppression, gastrointestinal hypermotility, digestive disorders

• Behavioral disorders in children, tics, stuttering, nausea, and vomiting

Higher Doses:

• Psychomotor agitation in mania, acute and chronic schizophrenia, and dementia

• Delusions and hallucinations in psychotic disorders

• Behavior and character disorders in children

• Alcoholism and acute confusion

• Choreatic movements

Treatment should always be initiated under medical supervision with careful dose titration based on clinical response.

Therapeutic Class

• Butyrophenone Drugs

• Drugs Used in Tremor, Tics, and Related Disorders

Pharmacology

Halopid 5 mg acts by:

• Blocking postsynaptic dopamine D1 and D2 receptors in the mesolimbic system

• Reducing the release of hypothalamic and hypophyseal hormones

• Producing calmness, reducing aggression, and alleviating hallucinations and delusions

It also exhibits hypothermic, anorexiant, and CNS depressant-potentiating effects.

Dosage & Administration

Tablet:

• Moderate symptomatology: 0.5–3 mg, 2–3 times daily

• Severe symptomatology: 3–5 mg, 2–3 times daily

• Elderly patients: 0.5–4.5 mg, 2–3 times daily

• Chronic/resistant patients: 3–6 mg, 2–3 times daily

• Daily doses up to 100 mg may be required in some cases

Injection (IM/IV):

• Initial: 2–10 mg, repeated every 4–8 hours according to response

• Maximum: 18 mg daily

• Not recommended for children

Administration Tips:

• Dose should be individualized based on age, severity, and previous neuroleptic response

• Titration should be gradual to achieve optimal response

• Clinical supervision is essential

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Interactions

• May decrease insulin requirement: none reported

• May increase effects/toxicity of: tricyclic antidepressants, CNS depressants, antihypertensives, levodopa

• Other interactions: Anticoagulants, sympathomimetics, methyldopa

• Careful monitoring required when combined with other medications

Contraindications

Halopid 5 mg should not be used in:

• Comatose states or CNS depression due to alcohol or depressants

• Severe depressive states

• Parkinson’s syndrome (except levodopa-induced dyskinesias)

• Pre-existing Parkinson-like symptoms in elderly

• Hypersensitivity to Halopid or related neuroleptics

• Spastic diseases or basal ganglia lesions

Side Effects

• Common: Headache, vertigo, insomnia, drowsiness, lethargy, confusion, agitation, anxiety, hallucinations, restlessness

• Gastrointestinal: Dry mouth, heartburn, nausea, vomiting, anorexia, diarrhea, hypersalivation

• Other: Blurred vision, urinary retention

Pregnancy & Lactation

• Pregnancy: Avoid if possible due to risk of limb malformations and neonatal extrapyramidal effects

• Lactation: Excreted in breast milk; sedation or rigidity may occur in neonates

Precautions & Warnings

• May lower seizure threshold; monitor epileptic patients closely

• Caution in hepatic or renal impairment, pheochromocytoma, alcohol withdrawal, brain injury

• Avoid abrupt discontinuation when combined with antiparkinson agents

• Monitor for potentiation with analgesics or hypnotics

Overdose

• Symptoms: Exaggeration of pharmacologic effects, severe extrapyramidal reactions, hypotension, sedation, coma, respiratory depression

• Treatment: Supportive care, monitoring, and symptomatic management

Storage Conditions

• Store below 30°C

• Protect from light and moisture

• Keep out of reach of children.